© 2024 WOSU Public Media
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

AstraZeneca, IU School of Medicine COVID-19 Vaccine Trial On Hold

Side Effects Public Media | By Lauren Bavis
Published September 9, 2020 at 12:41 PM EDT
The COVID-19 vaccine trial will take place at the Clinical Research Center at IU Health University Hospital in Indianapolis.
Photo courtesy of Indiana University
The COVID-19 vaccine trial will take place at the Clinical Research Center at IU Health University Hospital in Indianapolis.

Pharmaceutical company AstraZeneca announced Wednesday morning that its COVID-19 vaccine trial is on hold after a volunteer in the UK had an unexplained illness.

The pause includes the trial set to take place through the Indiana University School of Medicine this fall. An IU School of Medicine spokesperson said IU had not begun enrolling vaccine trial participants and no one had been given a dose of the vaccine.

In a statement, AstraZeneca said unexplained illnesses will happen by chance in all large clinical trials, and it is standard procedure for those incidents to be independently reviewed. The company did not say what the unexplained illness was, or when trials will resume.

This story was produced by , a news collaborative covering public health.

Copyright 2021 Side Effects Public Media. To see more, visit .

Side Effects Public Media
Lauren Bavis
Lauren a reporter and editor based at WFYI in Indianapolis. She maintains Side Effects' website, social media accounts (which you can follow on Facebook and Twitter) and newsletter (which you should sign up to get weekly). Lauren graduated from Towson University and moved to Indiana in 2012, where she began her career as a newspaper reporter. She reported on health and social services for the Bloomington Herald-Times. Her work has been recognized by the Indiana chapters of the Society of Professional Journalists and Associated Press Media Editors, as well as the Hoosier State Press Association.
See stories by Lauren Bavis